Safety and use of tetanus-diphtheria-acellular pertussis-5 (Tdap5) vaccine during pregnancy: findings from 11 years of reporting to a pregnancy registry.
Saved in:
| Title: | Safety and use of tetanus-diphtheria-acellular pertussis-5 (Tdap5) vaccine during pregnancy: findings from 11 years of reporting to a pregnancy registry. |
|---|---|
| Authors: | Switzer C; Global Pharmacovigilance and Epidemiology, Sanofi Pasteur, Toronto, Ontario, Canada., Tikhonov I; Global Pharmacovigilance and Epidemiology, Sanofi Pasteur, Swiftwater, Pennsylvania, USA., Khromava A; Epidemiology and Benefit-Risk, Sanofi Pasteur, Toronto, Ontario, Canada., Pool V; Medical Affairs, Sanofi Pasteur, Swiftwater, PA, USA., Lévesque LE; Epidemiology and Benefit-Risk, Sanofi Pasteur, Toronto, Ontario, Canada. |
| Source: | Human vaccines & immunotherapeutics [Hum Vaccin Immunother] 2021 Dec 02; Vol. 17 (12), pp. 5325-5333. Date of Electronic Publication: 2021 Dec 29. |
| Publication Type: | Journal Article; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: Taylor & Francis Country of Publication: United States NLM ID: 101572652 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2164-554X (Electronic) Linking ISSN: 21645515 NLM ISO Abbreviation: Hum Vaccin Immunother Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 34965196 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Safety and use of tetanus-diphtheria-acellular pertussis-5 (Tdap5) vaccine during pregnancy: findings from 11 years of reporting to a pregnancy registry. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Switzer+C%22">Switzer C</searchLink>; Global Pharmacovigilance and Epidemiology, Sanofi Pasteur, Toronto, Ontario, Canada.<br /><searchLink fieldCode="AU" term="%22Tikhonov+I%22">Tikhonov I</searchLink>; Global Pharmacovigilance and Epidemiology, Sanofi Pasteur, Swiftwater, Pennsylvania, USA.<br /><searchLink fieldCode="AU" term="%22Khromava+A%22">Khromava A</searchLink>; Epidemiology and Benefit-Risk, Sanofi Pasteur, Toronto, Ontario, Canada.<br /><searchLink fieldCode="AU" term="%22Pool+V%22">Pool V</searchLink>; Medical Affairs, Sanofi Pasteur, Swiftwater, PA, USA.<br /><searchLink fieldCode="AU" term="%22Lévesque+LE%22">Lévesque LE</searchLink>; Epidemiology and Benefit-Risk, Sanofi Pasteur, Toronto, Ontario, Canada. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22101572652%22">Human vaccines & immunotherapeutics</searchLink> [Hum Vaccin Immunother] 2021 Dec 02; Vol. 17 (12), pp. 5325-5333. <i>Date of Electronic Publication: </i>2021 Dec 29. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article; Research Support, Non-U.S. Gov't – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Taylor+%26+Francis%22">Taylor & Francis </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>101572652 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>2164-554X (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2221645515%22">21645515 </searchLink><i>NLM ISO Abbreviation: </i>Hum Vaccin Immunother <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=34965196 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1080/21645515.2021.1915038 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 5325 Titles: – TitleFull: Safety and use of tetanus-diphtheria-acellular pertussis-5 (Tdap5) vaccine during pregnancy: findings from 11 years of reporting to a pregnancy registry. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Switzer C – PersonEntity: Name: NameFull: Tikhonov I – PersonEntity: Name: NameFull: Khromava A – PersonEntity: Name: NameFull: Pool V – PersonEntity: Name: NameFull: Lévesque LE IsPartOfRelationships: – BibEntity: Dates: – D: 02 M: 12 Text: 2021 Dec 02 Type: published Y: 2021 Identifiers: – Type: issn-electronic Value: 2164-554X Numbering: – Type: volume Value: 17 – Type: issue Value: 12 Titles: – TitleFull: Human vaccines & immunotherapeutics Type: main |
| ResultId | 1 |
